Harbor Capital Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-55,422
Closed -$487K 873
2023
Q4
$487K Buy
55,422
+14,423
+35% +$127K 0.09% 244
2023
Q3
$470K Buy
40,999
+9,307
+29% +$107K 0.1% 236
2023
Q2
$802K Buy
+31,692
New +$802K 0.16% 171